Inceptionr LLC Amicus Therapeutics, Inc. Transaction History

Inceptionr LLC

$410 Billion
Q3 2024

A detailed history of Inceptionr LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Inceptionr LLC holds 50,792 shares of FOLD stock, worth $489,126. This represents 0.13% of its overall portfolio holdings.

Number of Shares

50,792

Holding current value

$489,126

% of portfolio

0.13%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 08, 2024	BUY	$9.55 - $12.09 $485,063 - $614,075	50,792 New	50,792 $542 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $204,999 - $263,245	20,728 New	20,728 $253 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$277 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$270 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$235 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$231 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$223 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.

Account